Exagen Inc. (XGN)

USD 4.24

(0.24%)

Net Debt Summary of Exagen Inc.

  • Exagen Inc.'s latest annual net debt in 2023 was -12.77 Million USD , up 54.21% from previous year.
  • Exagen Inc.'s latest quarterly net debt in 2024 Q2 was -602 Thousand USD , up 84.12% from previous quarter.
  • Exagen Inc. reported annual net debt of -27.89 Million USD in 2022, up 61.24% from previous year.
  • Exagen Inc. reported annual net debt of -71.96 Million USD in 2021, down -133.73% from previous year.
  • Exagen Inc. reported quarterly net debt of -602 Thousand USD for 2024 Q2, up 84.12% from previous quarter.
  • Exagen Inc. reported quarterly net debt of -12.77 Million USD for 2023 Q4, down -202.08% from previous quarter.

Annual Net Debt Chart of Exagen Inc. (2023 - 2012)

Historical Annual Net Debt of Exagen Inc. (2023 - 2012)

Year Net Debt Net Debt Growth
2023 -12.77 Million USD 54.21%
2022 -27.89 Million USD 61.24%
2021 -71.96 Million USD -133.73%
2020 -30.78 Million USD 33.4%
2019 -46.23 Million USD -500.81%
2018 11.53 Million USD 51.86%
2017 7.59 Million USD 0.0%
2015 23.39 Million USD 68.16%
2014 13.91 Million USD 1087.03%
2013 1.17 Million USD 881.33%
2012 -150 Thousand USD 0.0%

Peer Net Debt Comparison of Exagen Inc.

Name Net Debt Net Debt Difference
Aclaris Therapeutics, Inc. -39.45 Million USD 67.626%
Applied DNA Sciences, Inc. -5.91 Million USD -115.961%
Aspira Women's Health Inc. -331 Thousand USD -3758.61%
Biodesix, Inc. 34.3 Million USD 137.229%
BioNexus Gene Lab Corp. -5.79 Million USD -120.361%
bioAffinity Technologies, Inc. -1.24 Million USD -927.571%
bioAffinity Technologies, Inc. -1.24 Million USD -927.571%
Bionano Genomics, Inc. 34.88 Million USD 136.615%
CareDx, Inc -47.97 Million USD 73.378%
Check-Cap Ltd. -24.75 Million USD 48.408%
Castle Biosciences, Inc. -83.53 Million USD 84.71%
DarioHealth Corp. -7.54 Million USD -69.21%
Exact Sciences Corporation 1.94 Billion USD 100.655%
Fulgent Genetics, Inc. -82.56 Million USD 84.531%
Guardant Health, Inc. 220.22 Million USD 105.799%
ICON Public Limited Company 3.56 Billion USD 100.359%
IDEXX Laboratories, Inc. 493.94 Million USD 102.586%
Illumina, Inc. 1.21 Billion USD 101.052%
Intelligent Bio Solutions Inc. -5.43 Million USD -135.097%
iSpecimen Inc. -2.14 Million USD -494.76%
Standard BioTools Inc. 46.5 Million USD 127.463%
MDxHealth SA 18.88 Million USD 167.63%
23andMe Holding Co. -141.37 Million USD 90.966%
Medpace Holdings, Inc. -103.32 Million USD 87.639%
Myriad Genetics, Inc. 88.1 Million USD 114.497%
Mainz Biomed B.V. 349.85 Thousand USD 3750.655%
ENDRA Life Sciences Inc. -2.43 Million USD -423.549%
NeoGenomics, Inc. 269.19 Million USD 104.745%
Neogen Corporation 735.62 Million USD 101.736%
Inotiv, Inc. 382.14 Million USD 103.342%
Natera, Inc. -200.1 Million USD 93.617%
OpGen, Inc. 11.89 Million USD 207.401%
OPKO Health, Inc. 230.68 Million USD 105.537%
Psychemedics Corporation 334 Thousand USD 3923.952%
Prenetics Global Limited -43.33 Million USD 70.529%
Prenetics Global Limited -43.33 Million USD 70.529%
Precipio, Inc. -386 Thousand USD -3208.808%
Personalis, Inc. -8.02 Million USD -59.212%
RadNet, Inc. 1.14 Billion USD 101.112%
Sera Prognostics, Inc. -2.02 Million USD -531.652%
Sotera Health Company 2.02 Billion USD 100.631%
Neuronetics, Inc. 2.79 Million USD 556.632%
Star Equity Holdings, Inc. -15.33 Million USD 16.724%
Star Equity Holdings, Inc. -15.33 Million USD 16.724%
Trinity Biotech plc 63.73 Million USD 120.039%
T2 Biosystems, Inc. 33.8 Million USD 137.777%
Twist Bioscience Corporation -192.4 Million USD 93.362%